Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques

Qingwen Zhang; Qiong Wang; Guang Tian; Zhizhen Qi; Xuecan Zhang; Xiaohong Wu; Yefeng Qiu; Yujing Bi; Xiaoyan Yang; Youquan Xin; Jian He; Jiyuan Zhou; Lin Zeng; Ruifu Yang; Xiaoyi Wang
February 2014
Human Vaccines & Immunotherapeutics;Feb2014, Vol. 10 Issue 2, p1
Academic Journal
No abstract available.


Related Articles

  • Role of the Yersinia pestis Yersiniabactin Iron Acquisition System in the Incidence of Flea-Borne Plague. Sebbane, Florent; Jarrett, Clayton; Gardner, Donald; Long, Daniel; Hinnebusch, B. Joseph // PLoS ONE;2010, Vol. 5 Issue 12, p1 

    Plague is a flea-borne zoonosis caused by the bacterium Yersinia pestis. Y. pestis mutants lacking the yersiniabactin (Ybt) siderophore-based iron transport system are avirulent when inoculated intradermally but fully virulent when inoculated intravenously in mice. Presumably, Ybt is required to...

  • Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination. Derbise, Anne; Hanada, Yuri; Khalifé, Manal; Carniel, Elisabeth; Demeure, Christian E. // PLoS Neglected Tropical Diseases;10/16/2015, Vol. 9 Issue 10, p1 

    Background: No efficient vaccine against plague is currently available. We previously showed that a genetically attenuated Yersinia pseudotuberculosis producing the Yersinia pestis F1 antigen was an efficient live oral vaccine against pneumonic plague. This candidate vaccine however failed to...

  • Yopp-Expressing Variant ofY. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia. Zauberman, Ayelet; Flashner, Yehuda; Levy, Yinon; Vagima, Yaron; Tidhar, Avital; Cohen, Ofer; Bar-Haim, Erez; Gur, David; Aftalion, Moshe; Halperin, Gideon; Shafferman, Avigdor; Mamroud, Emanuelle // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Plague, initiated by Yersinia pestis infection, is a rapidly progressing disease with a high mortality rate if not quickly treated. The existence of antibiotic-resistant Y. pestis strains emphasizes the need for the development of novel countermeasures against plague. We previously reported the...

  • Genotyping and Phylogenetic Analysis of Yersinia pestis by MLVA: Insights into the Worldwide Expansion of Central Asia Plague Foci. Yanjun Li; Yujun Cui; Hauck, Yolande; Platonov, Mikhail E.; Dai, Erhei; Yajun Song; Zhaobiao Guo; Pourcel, Christine; Dentovskaya, Svetlana V.; Anisimov, Andrey P.; Ruifu Yang; Vergnaud, Gilles // PLoS ONE;2009, Vol. 4 Issue 6, p1 

    Background: The species Yersinia pestis is commonly divided into three classical biovars, Antiqua, Medievalis, and Orientalis, belonging to subspecies pestis pathogenic for human and the (atypical) non-human pathogenic biovar Microtus (alias Pestoides) including several non-pestis subspecies....

  • Plague case shows signs of multidrug resistance. Wise, Jacqui // BMJ: British Medical Journal (International Edition);09/13/97, Vol. 315 Issue 7109, p623 

    Reports on the identification of a high level of resistance to multiple antibiotics in a strain of Yersinia pestis isolated from a patient with bubonic plague from Madagascar. Resistance to principal alternative drugs for treatment and prophylaxis of plague; Transmission of the...

  • Dynamics of CRISPR Loci in Microevolutionary Process of Yersinia pestis Strains. Barros, Maria Paloma S.; França, Camila T.; Lins, Rosanny Holanda F. B.; Santos, Milena Danda V.; Silva, Ednaldo J.; Oliveira, Maria Betânia M.; Silveira-Filho, Vladimir M.; Rezende, Antônio M.; Balbino, Valdir Q.; Leal-Balbino, Tereza Cristina // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    The potential use of CRISPR loci genotyping to elucidate population dynamics and microevolution of 146 Yersinia pestis strains from different biovars and locations was investigated in this work. The majority of strains from the Orientalis biovar presented specific spacer arrays, allowing for the...

  • Plague Vaccine Development: Current Research and Future Trends. Verma, Shailendra Kumar; Tuteja, Urmil // Frontiers in Immunology;12/14/2016, Vol. 7, p1 

    Plague is one of the world's most lethal human diseases caused by Yersinia pestis, a Gram-negative bacterium. Despite overwhelming studies for many years worldwide, there is no safe and effective vaccine against this fatal disease. Inhalation of Y. pestis bacilli causes pneumonic plague, a fast...

  • WHAT WAS THE BLACK DEATH? Truitt, Elly // Calliope;Mar2001, Vol. 11 Issue 7, p12 

    Focuses on three types of plague that devastated Europe in the 14th century. Origin of the bubonic plague; Transmission of bacterium Yersinia pestis into humans; Symptoms of a person infected with the bubonic plague; Airborne type of plague; Rarity of septicaemic plague.

  • An Encapsulated Yersinia pseudotuberculosis Is a Highly Efficient Vaccine against Pneumonic Plague. Derbise, Anne; Marín, Alba Cerdà; Ave, Patrick; Blisnick, Thierry; Huerre, Michel; Carniel, Elisabeth; Demeure, Christian E. // PLoS Neglected Tropical Diseases;Feb2012, Vol. 6 Issue 2, p1 

    Background: Plague is still a public health problem in the world and is re-emerging, but no efficient vaccine is available. We previously reported that oral inoculation of a live attenuated Yersinia pseudotuberculosis, the recent ancestor of Yersinia pestis, provided protection against bubonic...

  • Evolutionary genetics: CCR5 mutation and plague protection. Mecsas, Joan; Franklin, Greg; Kuziel, William A.; Brubaker, Robert R.; Falkow, Stanley; Mosier, Donald E. // Nature;2/12/2004, Vol. 427 Issue 6975, p606 

    A recent and prevalent mutation in the chemokine receptor CCR5 in humans of northern European ancestry has been proposed to provide protection against bubonic plague. Here we infect both normal and CCR5-deficient mice with the bacterium Yersinia pestis, the cause of the plague epidemics that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics